California Public Employees Retirement System
NVCR icon

California Public Employees Retirement System’s NovoCure NVCR Stock Holding History

California Public Employees Retirement System’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-153,406
Closed -$2.29M – 1190
2023
Q4 		$2.29M Hold
153,406
– – ﹤0.01% 1160
2023
Q3 		$2.48M Sell
153,406
-37,581
-20% -$1.08M ﹤0.01% 1155
2023
Q2 		$7.93M Sell
190,987
-6,063
-3% -$376K 0.01% 946
2023
Q1 		$11.9M Sell
197,050
-31,603
-14% -$2.53M 0.01% 784
2022
Q4 		$16.8M Buy
228,653
+19,246
+9% +$1.45M 0.01% 686
2022
Q3 		$15.9M Buy
209,407
+23,686
+13% +$1.85M 0.01% 669
2022
Q2 		$12.9M Sell
185,721
-8,389
-4% -$632K 0.01% 697
2022
Q1 		$16.1M Sell
194,110
-33,285
-15% -$2.45M 0.01% 689
2021
Q4 		$17.1M Sell
227,395
-1,220
-0.5% -$122K 0.01% 733
2021
Q3 		$26.6M Sell
228,615
-2,722
-1% -$412K 0.02% 566
2021
Q2 		$51.3M Sell
231,337
-7,934
-3% -$1.54M 0.04% 414
2021
Q1 		$31.6M Buy
239,271
+17,273
+8% +$2.73M 0.02% 542
2020
Q4 		$38.4M Buy
221,998
+13,335
+6% +$1.82M 0.03% 466
2020
Q3 		$23.2M Sell
208,663
-14,517
-7% -$1.16M 0.02% 540
2020
Q2 		$13.2M Buy
223,180
+27,777
+14% +$1.83M 0.01% 682
2020
Q1 		$13.2M Sell
195,403
-37,879
-16% -$2.99M 0.02% 593
2019
Q4 		$19.7M Buy
233,282
+43,710
+23% +$3.53M 0.02% 621
2019
Q3 		$14.2M Buy
189,572
+49,924
+36% +$3.99M 0.01% 711
2019
Q2 		$8.83M Sell
139,648
-440
-0.3% -$22.3K 0.01% 803
2019
Q1 		$6.75M Sell
140,088
-1,600
-1% -$77K 0.01% 1002
2018
Q4 		$4.74M Sell
141,688
-4,947
-3% -$181K 0.01% 1152
2018
Q3 		$7.68M Buy
146,635
+78,514
+115% +$3.13M 0.01% 1035
2018
Q2 		$2.13M Sell
68,121
-17,981
-21% -$500K ﹤0.01% 1864
2018
Q1 		$1.88M Buy
+86,102
New +$1.85M ﹤0.01% 1924

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System's NVCR Position: Q1 2024 in Review

California Public Employees Retirement System sold out of NovoCure (NVCR) in Q1 2024, closing a stake of 153,406 shares — an estimated $2.29M sold.

California Public Employees Retirement System first reported a position in NVCR in Q1 2018 and held it in 24 quarters. The position peaked at $51.3M in Q2 2021. 238 funds tracked by Wall St. Rank hold NVCR as of Q1 2024.

  • California Public Employees Retirement System reported no remaining NovoCure position as of Q1 2024 after selling out during the quarter.
  • California Public Employees Retirement System sold 153,406 NovoCure shares in Q1 2024, an estimated $2.29M.
  • California Public Employees Retirement System first reported a position in NovoCure in Q1 2018 and held it in 24 quarters.
  • California Public Employees Retirement System's NovoCure position peaked at $51.3M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held NovoCure as of Q1 2024.

Based on California Public Employees Retirement System's 13F filing for Q1 2024, filed 30 Apr 2024.